Barclays
NTRB icon

Barclays’s Nutriband NTRB Stock Holding History

Barclays’s Portfolio NTRB Stock Details NTRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18
Closed -$127 – 5543
2025
Q3 		$127 Buy
+18
New +$131 ﹤0.01% 5262

Other funds holding NTRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CPW
Cogent Private Wealth Orlando, Florida $139M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HP
Haven Private Orlando, Florida $263M AUM 21.06% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays's NTRB Position: Q4 2025 in Review

Barclays sold out of Nutriband (NTRB) in Q4 2025, closing a stake of 18 shares — an estimated $127 sold.

Barclays first reported a position in NTRB in Q3 2025 and held it in 1 quarter. The position peaked at $127 in Q3 2025. 19 funds tracked by Wall St. Rank hold NTRB as of Q4 2025.

  • Barclays reported no remaining Nutriband position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 18 Nutriband shares in Q4 2025, an estimated $127.
  • Barclays first reported a position in Nutriband in Q3 2025 and held it in 1 quarter.
  • Barclays's Nutriband position peaked at $127 in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Nutriband as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.